All In Biotech

Free tool

FAERS Monitor: Micafungin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212125 or its brand name (Micafungin, Micafungin Sodium). Reports on generic versions are filed under their own applications.

Reports

6,576

Serious

6,281

96% of reports

Hospitalization

3,207

Death reported

2,438

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,105
  • off label use691
  • pyrexia487
  • febrile neutropenia435
  • product use in unapproved indication320
  • pneumonia313
  • sepsis308
  • multiple organ dysfunction syndrome281
  • diarrhoea271
  • neutropenia264
  • acute kidney injury254
  • respiratory failure244
  • septic shock229
  • condition aggravated202
  • bronchopulmonary aspergillosis182

Reports by year received

View as table
YearReports
200411
200518
200630
200755
200849
200948
201085
2011172
2012200
2013143
2014175
2015315
2016259
2017353
2018460
2019481
2020459
2021539
2022529
2023568
2024577
2025605
2026445

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,583 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bronchopulmonary aspergillosisSignal18276.866.513,236
multiple organ dysfunction syndromeSignal28132.028.68,346
febrile neutropeniaSignal43521.119.38,283
septic shockSignal22916.914.93,403
respiratory failureSignal24410.79.52,144
sepsisSignal3088.97.92,143
neutropeniaSignal2646.25.51,157
acute kidney injurySignal2545.34.7891
pyrexiaSignal4874.54.11,346
product use in unapproved indicationSignal3204.13.7765
pneumoniaSignal3133.12.8448
drug ineffectiveSignal1,1052.72.51,242
off label useSignal6912.52.4662
condition aggravatedSignal2022.11.9121
diarrhoea2711.31.224

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.